JPMorgan analyst Jessica Fye downgraded Emergent BioSolutions to Underweight from Neutral with a price target of $9, down from $23.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EBS:
JPMorgan analyst Jessica Fye downgraded Emergent BioSolutions to Underweight from Neutral with a price target of $9, down from $23.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EBS: